Sudeep Pharma Ltd
Company Profile
Business description
Sudeep Pharma Ltd is engaged in the business of manufacturing and selling pharmaceutical and nutraceutical products and intermediaries used by the pharmaceutical and nutraceutical industries globally. It operates through the Pharmaceutical, Food and Nutrition segment, which generates maximum revenue, and the Speciality Ingredients segment. The Pharmaceutical, Food and Nutrition segment pertains to the manufacturing of pharmaceutical excipients and functional food ingredients. The Speciality Ingredients segment pertains to the manufacturing of specialty ingredients using technology to produce micronutrient premixes, liposomal ingredients, encapsulated ingredients, spray-dried ingredients, granulated ingredients and triturates. It generates maximum revenue from India.
Contact
Gotri-Sevasi Road
601-602, 6th floor, Sears Towers-2, East Wing
Sevasi
VadodaraGJ390021
INDT: +91 2652840656
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
651
Stocks News & Analysis
stocks
Disney earnings: Experiences and streaming again drive excellent results
stocks
ASX utility share downgraded as electricity prices fall
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,445.10 | 33.80 | 0.36% |
| CAC 40 | 8,714.93 | 15.22 | 0.17% |
| DAX 40 | 26,319.45 | 179.32 | 0.69% |
| Dow JONES (US) | 54,036.93 | 151.83 | 0.28% |
| FTSE 100 | 10,901.09 | 33.20 | 0.31% |
| HKSE | 25,668.03 | 137.75 | 0.54% |
| NASDAQ | 26,690.62 | 342.26 | 1.30% |
| Nikkei 225 | 65,606.71 | 76.55 | -0.12% |
| NZX 50 Index | 13,824.13 | 133.93 | -0.96% |
| S&P 500 | 7,757.64 | 47.68 | 0.62% |
| S&P/ASX 200 | 9,263.60 | 34.80 | 0.38% |
| SSE Composite Index | 3,940.04 | 39.68 | 1.02% |